Phase 2
18 Years
78 Years
18 Years
78 Years
Open (Enrolling)
Both
Lung Cancer,, Postoperative Pain
Both
Lung Cancer,, Postoperative Pain
Trial Information
Inclusion Criteria:
- Age; 18≥, <75
- Thoracoscopic lobectomy due to lung cancer or suspected lung cancer
- Tolerable cardiopulmonary and other systemic function tolerable to lobectomy
- Karnofsky performance status ≥ 80
- Agree with study
Exclusion Criteria:
- Intolerable to one-lung ventilation
- Bleeding risk due to Aspirin, coumadin and other drugs
- Past or current history of depression or other psychiatric disease
- Pain persisted before operation due to lung lesion
- History of rib fracture, trauma or lung surgery at the same side of operation
- Severe pleural adhesion or empyema
- Open thoracotomy conversion
- Reoperation due to postoperative bleeding or others
- Postoperative complications that need ICU care
- Chemical pleurodesis more than two times after operation
- Do not agree with study
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
Outcome Measure:
1. Acute pain
Outcome Time Frame:
Pain score(Visual Analogue Scale) measured in operative day, POD #1, #2, #3, #4)
Safety Issue:
No
Authority:
Korea: Institutional Review Board
Study ID:
4-2012-0470
NCT ID:
NCT01703351
Start Date:
October 2012
Completion Date:
October 2013
Related Keywords:
- Lung Cancer,
- Postoperative Pain
- pain control, VATS
- Lung Neoplasms
- Pain, Postoperative
Name | Location |
|---|
